Artgen Biotech PJSC Balance Sheet

Financials in millions RUB. Fiscal year is January - December.

Millions RUB. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	565.37	503.35	544.94	201.66	193.29
Trading Asset Securities	-	35.11	27.39	25.4	0.51
Cash & Short-Term Investments	565.37	538.46	572.33	227.06	193.8
Cash Growth	5.00%	-5.92%	152.07%	17.16%	79.61%
Accounts Receivable	83.66	67.3	81.83	67.86	83.2
Other Receivables	83.54	52.33	72.58	61.69	23.92
Receivables	167.2	189.6	205.38	185.11	131.76
Inventory	177.78	246.84	226.31	223.87	245.79
Other Current Assets	480.07	97.94	113.22	53.74	86.71
Total Current Assets	1,390	1,073	1,117	689.77	658.06
Property, Plant & Equipment	374.98	376.86	315.87	280.51	285
Long-Term Investments	85.32	96.91	161.33	193.34	120.62
Other Intangible Assets	881.14	347.92	174.9	150.1	128.6
Long-Term Deferred Tax Assets	138.21	115.23	90.83	83.03	86.12
Long-Term Deferred Charges	-	510.21	631.35	586.62	414.09
Other Long-Term Assets	117.67	-	-	-	-
Total Assets	2,988	2,671	2,544	2,045	1,737
Accounts Payable	80.88	54.92	53.41	33.87	35.94
Accrued Expenses	23.38	-	-	-	-
Short-Term Debt	398.65	-	0.73	0.73	0.2
Current Portion of Long-Term Debt	-	87.71	219.72	106.44	-
Current Portion of Leases	27.08	25.17	19.53	11.69	8.89
Current Income Taxes Payable	-	15	24.84	24.57	14.61
Other Current Liabilities	246.5	286.11	243.16	218.28	312.52
Total Current Liabilities	776.49	468.91	561.4	395.57	372.15
Long-Term Debt	422.41	480.5	427.2	601.38	494.23
Long-Term Leases	116.85	144.28	119.77	111.36	113.82
Other Long-Term Liabilities	530.69	504.13	460.96	366	296.49
Total Liabilities	1,846	1,598	1,569	1,474	1,277
Common Stock	9.27	9.27	9.27	9.27	8.5
Additional Paid-In Capital	638.99	626.58	625.13	612.1	567.43
Retained Earnings	424.4	365.43	241.53	146.45	94.13
Treasury Stock	-497.68	-499.39	-421.99	-447.85	-446.98
Comprehensive Income & Other	-101.21	-94.51	-30.06	21.07	11.7
Total Common Equity	473.77	407.37	423.87	341.04	234.78
Minority Interest	667.52	666.25	550.86	229.22	225.78
Shareholders' Equity	1,141	1,074	974.73	570.26	460.56
Total Liabilities & Equity	2,988	2,671	2,544	2,045	1,737
Total Debt	964.99	737.65	786.96	831.6	617.13
Net Cash (Debt)	-399.62	-199.2	-214.62	-604.55	-423.33
Net Cash Per Share	-5.32	-2.15	-2.32	-6.96	-5.29
Filing Date Shares Outstanding	74.08	73.76	75.15	81.61	85
Total Common Shares Outstanding	74.08	73.76	75.15	81.61	85
Working Capital	613.93	603.94	555.84	294.2	285.9
Book Value Per Share	6.40	5.52	5.64	4.18	2.76
Tangible Book Value	-407.37	59.45	248.97	190.94	106.18
Tangible Book Value Per Share	-5.50	0.81	3.31	2.34	1.25
Buildings	-	63.02	67.06	49.65	97.89
Machinery	-	419.13	375.42	353.72	336.45
Construction In Progress	-	16.15	-	-	0.05

Source: S&P Global Market Intelligence. Standard template. Financial Sources.